The population benefit of radiotherapy for cervical cancer: Local control and survival estimates for optimally utilized radiotherapy and chemoradiation

Radiotherapy and Oncology

Volumn 114, Issue 3, 2015, Pages 389-394

  Hanna, T P ^a   Shafiq, J ^a   Delaney, G P ^a   Barton, M B ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cervical cancer; Chemoradiation; Demand model; Effectiveness; Population benefit; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADVANCED CANCER; ARTICLE; AUSTRALIAN; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; DATA BASE; DECISION TREE; EMBASE; EXTERNAL BEAM RADIOTHERAPY; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POPULATION; PRIORITY JOURNAL; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT INDICATION; UTERINE CERVIX CANCER; ADJUVANT THERAPY; AUSTRALIA; CANCER STAGING; CHEMORADIOTHERAPY; FEMALE; MORTALITY; PATHOLOGY; UTERINE CERVICAL NEOPLASMS;

AUSTRALIA; CHEMORADIOTHERAPY; FEMALE; HUMANS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; UTERINE CERVICAL NEOPLASMS;

EID: 84927574397     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.02.005     Document Type: Article

References (50)

1. T.P. Hanna, and J. Shafiq Estimating the population benefit of radiotherapy: using demand models to estimate achievable cancer outcomes Clin Oncol (R Coll Radiol) 27 2015 99 106
2. M. Kerba Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach Clin Oncol (R Coll Radiol) 19 2007 481 489
3. G. Delaney The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines Cancer 104 2005 1129 1137
4. M.B. Barton, M. Frommer, and J. Shafiq Role of radiotherapy in cancer control in low-income and middle-income countries Lancet Oncol 7 2006 584 595
5. R. Jena The Malthus programme - a new tool for estimating radiotherapy demand at a local level Clin Oncol (R Coll Radiol) 24 2012 1 3
6. N. Usmani An evidence-based estimate of the appropriate rate of utilization of radiotherapy for cancer of the cervix Int J Radiat Oncol Biol Phys 63 2005 812 827
7. L. Barbera Estimating the benefit and cost of radiotherapy for lung cancer Int J Technol Assess Health Care 20 2004 545 551
8. J. Shafiq, G. Delaney, and M.B. Barton An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer Radiother Oncol 84 2007 11 17
9. G. Delaney, S. Jacob, and M. Barton Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I - malignancies of the cervix, ovary, vagina and vulva Cancer 101 2004 671 681
10. National Health and Medical Research Council, NHMRC levels of evidence and grades for recommendations for developers of guidelines. 2009: Australian Government.
11. Ng, W.L., Estimating the optimal chemotherapy utilisation rate as an evidence-based benchmark in cancers of the breast, upper gastrointestinal tract, gynaecological tract, head and neck, kidney, bladder, thyroid and unknown primary. 2010. Sydney, Australia: University of New South Wales (Ph. D Thesis).
12. M.B. Shimkin, M.H. Griswold, and S.J. Cutler Classics in oncology. Survival in untreated and treated cancer CA Cancer J Clin 34 1984 282 294
13. W. Ng Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: setting an evidence-based benchmark for the best-quality cancer care Eur J Cancer 45 2009 2150 2159
14. G. Delaney, S. Jacob, and M. Barton Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma Cancer 103 2005 2216 2227
15. C.B. Borkowf A simple hybrid variance estimator for the Kaplan-Meier survival function Stat Med 24 2005 827 851
16. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
17. J.F. Tierney Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 2007 16
18. Greater Metropolitan Clinical Taskforce, Best Clinical Practice Gynaecological Cancer Guidelines. 2009, North Sydney, NSW: NSW Department of Health.
19. National Cancer Institute, Cervical Cancer Treatment PDQ Health Professional Version Available at http://www.cancer.gov/cancertopics/pdq/adulttreatment. 2012.
20. National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology-v 2.2013-Cervical Cancer. Available at http://www.nccn.org. 2013.
21. Alberta Health Services, Cancer of the Uterine Cervix Clinical Practice Guideline GYNE-004 Available at: http://www.albertahealthservices.ca. 2012, Alberta.
22. Vergote, I., et al., Een nationale praktijkrichtlijn voor de aanpak van cervixkanker. Good Clinical Practice (GCP). 2011, Brussels: Federaal Kenniscentrum voor de Gezondheidszorg (KCE).
23. BC Cancer Agency, Uterine Cervix Management Invasive - Squamous Cell Carcinoma & Adenocarcinoma. Available at http://www.bccancer.bc.ca. 2006: BC Cancer Agency.
24. C. Haie-Meder, P. Morice, and M. Castiglione Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 2010 v37 v40
25. Scottish Intercollegiate Guidelines Network, 99 Management of cervical cancer: A national clinical guideline. Available at http://www.sign.ac.uk. 2008.
26. Lukka, H., et al., Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-based Chemotherapy and Radiation. Practice Guideline Report #4-5, in Program in Evidence-Based Care. 2004, Cancer Care Ontario.
27. eviQ, Radiation Oncology, Gynaecological, Cervix, Definitive, EBRT 2013: Cancer Institute; NSW.
28. Gaffney, D.K., et al., Advanced Cervical Cancer. ACR Appropriateness Criteria. 2012: American College of Radiology.
29. Sydney Gynaecological Oncology Group. Cervical Cancer. 2012 5 Jan 2012; Available from: http://www.sswahs.nsw.gov.au/SSWAHS/sgog/Vulva-Guide.html.
30. YCN Gynaecology Network Site Specific Group, Guidelines for the Management of Gynaecological Cancers. 2012: Yorkshire Cancer Network.
31. R.G. Stock Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure Int J Radiat Oncol Biol Phys 31 1995 31 36
32. B.J. Monk Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial Gynecol Oncol 96 2005 721 728
33. W.A. Peters 3rd Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
34. M. Rotman A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study Int J Radiat Oncol Biol Phys 65 2006 169 176
35. D. Smaniotto Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome Tumori 91 2005 295 301
36. G.M. Thomas Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery Int J Gynecol Cancer 3 1993 193 198
37. F.B. Stehman Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial Am J Obstet Gynecol 197 2007 (p. 503 e1-6)
38. National Cancer Institute, SEER Stat 6.6.2. 2010, Silver Spring, MD: The Surveillance Research Program of the Division of Cancer Control and Population Sciences, National Cancer Institute.
39. Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC), Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst Rev, 2010(1). p. CD008285.
40. V. Lorvidhaya Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial Int J Radiat Oncol Biol Phys 55 2003 1226 1232
41. K.B. Roberts Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix Int J Cancer 90 2000 206 223
42. M. Rotman Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20 JAMA 274 1995 387 393
43. M.H. Tattersall, C. Ramirez, and M. Coppleson A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer Int J Gynecol Cancer 2 1992 244 251
44. N. Yamauchi A randomized trial of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy alone in Stage IIIb carcinoma of the uterine cervix J Gynecol Surg 26 2010 105 113
45. R.E. Estape Close vaginal margins as a prognostic factor after radical hysterectomy Gynecol Oncol 68 1998 229 232
46. A.N. Viswanathan Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer Int J Radiat Oncol Biol Phys 65 2006 1501 1507
47. Ferlay, J., et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Available from: http://globocan.iarc.fr, accessed on 27 September 2014. 2013, Lyon, France: International Agency for Research on Cancer.
48. Barton, M.B., et al., Review of optimal radiotherapy utilisation rates. http://tinyurl.com/pwkua34. 2012, Sydney: Ingham Institute, Collaboration for Cancer Outcomes Research and Evaluation.
49. M.B. Barton Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012 Radiother Oncol 112 2014 140 144
50. R. Pearcey Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study J Clin Oncol 25 2007 2383 2388